Best Washington Grants for Nonprofits in District of Columbia

This funding opportunity invites applications for pilot projects focused on understudied proteins linked to rare diseases. The goal is to generate preliminary data and tools related to these proteins, which belong to druggable families with known rare disease associations. By supporting innovative research, this initiative aims to facilitate the characterization of these proteins, ultimately contributing to advancements in understanding and treating rare diseases.

This Funding Opportunity Announcement (FOA) aims to advance the identification and evaluation of candidate biomarkers for neurological and neuromuscular disorders. By facilitating the clinical development of neurotherapeutics, the FOA encourages research that includes both animal studies and preliminary human evaluations. The ultimate goal is to produce biomarkers ready for rigorous analytical and clinical validation, enhancing the effectiveness of treatments in clinical practice.

The Limited Competition: Basic Instrumentation Grant (BIG) Program offers funding to NIH-supported researchers for purchasing specialized instruments or integrated systems, with minimum awards of $25,000 and maximum awards reaching $350,000. Eligibility is restricted to institutions that have not received significant S10 funding in recent years. This program aims to enhance research capabilities by providing access to essential technology, thereby fostering scientific innovation and collaboration within the NIH community.

The Shared Instrumentation Grant (SIG) Program supports NIH-funded investigators in acquiring high-cost, specialized instruments, with a minimum award of $50,000 and a maximum of $750,000. Eligible instruments include light microscopes, mass spectrometers, and DNA sequencers, among others. This program aims to enhance research capabilities by enabling the purchase or upgrade of essential equipment for scientific advancement.

The High-End Instrumentation (HEI) Grant Program, offered by the NIH, invites applications for purchasing or upgrading high-end, specialized instruments, with a minimum award of $750,001 and a maximum of $2,000,000. This program supports NIH investigators aiming to enhance their research capabilities through advanced technologies such as mass spectrometers and electron microscopes. Applications must be submitted by 5:00 pm local time of the applicant organization.

The NIH is seeking innovative computational approaches to enhance the curation of biomedical research assets at scale. This initiative aims to accelerate access to secure datasets and computational models, facilitating transformative discoveries in biomedical science. Key deadlines for applications range from January 2025 to January 2027, covering standard, renewal, and AIDS-related grants. Applicants are encouraged to submit Letters of Intent 30 days prior to application deadlines to ensure a streamlined review process.

The Reboot Representation Tech Coalition aims to significantly increase the number of Black, Latina, and Native American women earning computing bachelor’s degrees. They invite qualified organizations to submit grant inquiries focused on recruiting and retaining these women in tech. Programs that leverage existing resources and operate across multiple regions will be prioritized, and the Coalition seeks initiatives backed by substantial research and community trust.

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program, funded by the NIH, aims to enhance the biomedical research landscape by supporting resource-limited organizations. It targets domestic institutions with limited research resources and few doctoral students in biomedical fields, promoting broader participation in research and boosting administrative capacities for sponsored programs. Applications are due by 5:00 PM local time of the applicant organization, ensuring timely submissions.

This grant opportunity from the NIH aims to enhance mechanistic research on precision probiotic therapies through a biphasic R61/R33 award mechanism. It encourages innovative studies to identify specific biological factors influencing probiotic responses, thereby improving clinical outcomes. The program supports up to five years of research, with the initial phase focused on discovering unique host characteristics and the second phase assessing improvements in probiotic efficacy through rigorous studies.

This funding opportunity aims to advance mechanistic research for precision probiotic therapies. It invites R33 applications focused on characterizing individual differences in probiotic responses, identifying responder subgroups, and enhancing clinical outcomes. The goal is to develop strategies addressing barriers to effective probiotic use, accounting for human variability. Proposals should include innovative studies using animal models or human subjects, supported by preliminary data to test biological patterns and their effects on health outcomes.

The Extramural Discovery Science Accelerator Award supports the commercialization of ongoing cancer research projects, focusing on experiments that facilitate technology validation and de-risking. Applications are accepted on a rolling basis, with a budget of up to $75,000 for one year. This award encourages independent investigators at any career stage to advance their technologies, with a strong emphasis on commercial viability and collaboration within a learning community.

The Leukemia Exploration and Prevention Grant Program (LEAP) aims to advance cancer interception and prevention for patients with RUNX1 familial platelet disorder (RUNX1-FPD). This program supports interdisciplinary research teams investigating the mechanisms of leukemogenesis and innovative treatment strategies. With funding of up to $430,000 per year, LEAP encourages projects focused on both understanding clonal evolution and developing novel therapeutic approaches. The initiative seeks to bridge critical knowledge gaps and provide urgent interventions for high-risk populations.

The Leukemia Exploration and Prevention Grant Program (LEAP) aims to advance cancer interception and prevention strategies for patients with RUNX1 familial platelet disorder. This initiative, supported by the American Cancer Society, focuses on understanding the mechanisms behind leukemia development and fostering innovative research leading to effective treatment options. Grants of up to $215,000 per year for four years are available, emphasizing the urgent need for targeted therapies in high-risk populations.

The Green Chemistry Student Chapter Award recognizes ACS student chapters for their commitment to green chemistry initiatives. This award highlights the importance of green chemistry in education, encouraging students to engage in activities that promote sustainability. Eligible chapters must submit detailed summaries of at least three green chemistry projects, demonstrating their understanding of the principles and practices that contribute to a more sustainable future.

The CCRP Initiative invites applications for basic research on chemical threats affecting the nervous system, including chemical warfare agents and toxic industrial chemicals. This funding aims to elucidate toxicity mechanisms, explore new toxic exposure manifestations, and identify targets for therapeutic development. Proposals should generate data relevant to understanding these toxic threats, with applications due by 5 PM local time. Optional Letters of Intent are encouraged 30 days prior to the proposal deadline.

The Mike & Sofia Segal Foundation Grant provides vital funding to nonprofit organizations focused on intellectual freedom, medical research for rare diseases, Jewish heritage preservation, elder care, and climate change initiatives. By supporting innovative projects that align with their mission, the foundation aims to uplift communities and foster meaningful societal contributions. Organizations must be 501c-3 compliant and demonstrate a clear plan for engagement with beneficiaries and measurable objectives to be eligible for funding.

The ASH HONORS Award supports emerging hematologists, offering $5,000 for research projects and a $1,000 annual travel allowance for two years. Targeted at first- and second-year medical students and residents, the award encourages ongoing research careers in hematology. Recipients attend an orientation at the ASH annual meeting, gaining insights from experienced professionals. Eligibility includes current ASH membership and a research mentor, while restrictions apply to prior HONORS awardees and those with concurrent funding.

The HIP Graduate Student Award supports first to third-year graduate students in the U.S., Canada, and Mexico aiming for a career in academic hematology. Offering a $40,000 annual stipend for two years, it funds tuition, research, and travel to the ASH annual meeting. Eligible candidates must conduct blood sciences research and demonstrate commitment to the field. This award enhances students' competitiveness for future opportunities in hematology research.

The HIP Medical Student Award by the American Society of Hematology supports underrepresented medical students in hematology research. Participants gain mentorship, a stipend up to $32,000, and valuable exposure to hematology practices. The program offers summer, flexible, and yearlong project options to accommodate students at different stages of their medical education. This initiative aims to foster diversity in the field and encourage long-term involvement in hematology.

The ASH Medical Student Physician-Scientist Award offers first-, second-, and third-year medical students a unique chance to engage in hematology research under the mentorship of an ASH member. This year-long project requires recipients to dedicate over 80% of their time to research, with funding totaling $42,000 for various expenses. Eligible candidates must be ASH members and actively enrolled in accredited medical programs in the U.S. or Canada, aiming for a career in hematology.

The Hematology Inclusion Pathway Resident Award supports underrepresented medical residents in hematology in the U.S., Canada, and Mexico. Participants receive $5,000 for research, mentorship from ASH members, and funding for the ASH annual meeting. Eligible candidates are in internal medicine or pediatric residencies, self-identify as underserved, and must conduct research with an ASH mentor. This program aims to enhance diversity and support crucial blood science research.

The ASH Graduate Hematology Award supports graduate students in the U.S. and Canada pursuing research in hematology. Offering a $40,000 annual stipend for two years, it covers tuition, research expenses, and travel to the ASH Annual Meeting. Eligible applicants must be PhD students in their first three years and have a mentor's support. This award aims to foster careers in academic hematology, encouraging innovative research in various hematologic fields.

The ASH Medical Educators Institute Grant Program aims to cultivate future leaders in hematology education through a comprehensive training initiative. This program includes workshops, webinars, and mentorship, designed for junior faculty and senior fellows in the U.S. and Canada. Participants enhance their teaching skills, develop scholarly projects, and build valuable professional networks. The initiative promotes diversity in medical education and seeks to empower educators dedicated to advancing the field of hematology.

The Hematology Inclusion Pathway Fellow Award supports early-career researchers from underrepresented communities in hematology in the U.S. and Canada. Offering up to $100,000 over two to three years, the award enables fellows to focus on hematology research and enhance their competitiveness for future awards. Eligible applicants include those with relevant degrees, who are in their first or second fellowship year, and have a committed ASH member mentor. This initiative aims to diversify the field of academic hematology.

The ASH Research Training Award for Fellows (RTAF) supports junior researchers in hematology and hematology-related fields. It offers $70,000 for one year, ensuring dedicated research time. Eligible MD and MD-PhD fellows can apply for a second year, aiding their competitiveness for further awards. The program emphasizes research in hematologic conditions and requires documented mentorship support. Awardees also receive $1,000 for ASH annual meeting attendance, fostering networking and professional development.

The AAAE Diversity, Equity & Inclusion Scholarship, provided by the AAAE Foundation, supports ethnic diversity students pursuing aviation studies in the U.S. or Canada. With two awards of $5,000 each, recipients are chosen based on their academic achievements, financial need, and community involvement. Eligible applicants include college juniors, seniors, or graduate students with a minimum GPA of 3.0. This scholarship aims to foster future leaders in the aviation industry, enhancing diversity and inclusion.

The Oris W. Dunham, Jr. and Sylvia M. Dunham Scholarship, offered by the AAAE Foundation, supports college students enrolled in aviation-related programs in the U.S. and Canada. Up to five non-renewable scholarships valued at $1,500 each will be awarded based on academic achievements, financial need, and community involvement. This initiative aims to foster future leaders in the aviation industry by providing financial assistance to deserving candidates.